Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Dolph
Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Cn6 - Cost-Effectiveness Model of Midostaurin (Mido) Versus Standard of Care (Soc) in Patients With Newly Diagnosed Flt3 Mutation-Positive (Flt3+) Acute Myeloid Leukemia (Aml): A French Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia
Journal of Pediatric Hematology/Oncology
Child Health
Oncology
Pediatrics
Hematology
Perinatology
Psy114 - Cost-Effectiveness of Vedolizumab Compared With Conventional Therapy in Patients With Crohn’s Disease in the United Kingdom (Uk)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effects of the Multi‐kinase Inhibitor Midostaurin in Combination With Chemotherapy in Models of Acute Myeloid Leukaemia
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
The Cost-Effectiveness of Supported Employment for Adults With Autism in the United Kingdom
Autism
Developmental
Educational Psychology
Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials
Future Oncology
Medicine
Cancer Research
Oncology
Strategic Options for Antenatal Screening for Syphilis in the United Kingdom: A Cost Effectiveness Analysis
Journal of Medical Screening
Health Policy
Public Health
Occupational Health
Environmental
Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
